Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 2/20 | 0.45 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.43 |
| ▸ | LSS | P48449 | 1/20 | 0.38 |
| ▸ | EP300 | Q09472 | 1/20 | 0.38 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.38 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.38 |
| ▸ | KDM1A | O60341 | 1/20 | 0.37 |
| ▸ | PPARG | P37231 | 2/20 | 0.37 |
| ▸ | GPR132 | Q9UNW8 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31744485 | 0.95 | PTPN1 (0.46) | PTPN1ACE2LSSEP300KDM1A | |
| SCHEMBL31744467 | 0.91 | PTPN1 (0.42) | PTPN1ACE2LSSEP300KDM1A | |
| SCHEMBL31753044 | 0.89 | PTPN1 (0.43) | PTPN1ACE2EP300KDM1A | |
| SCHEMBL30634967 | 0.89 | TSHR (0.47) | PTPN1ACE2LSS | |
| SCHEMBL9545639 | 0.85 | EP300 (0.48) | PTPN1LSSEP300PPARG | |
| SCHEMBL9545687 | 0.85 | EP300 (0.48) | PTPN1LSSEP300PPARG | |
| SCHEMBL9446475 | 0.85 | EP300 (0.48) | PTPN1LSSEP300PPARG | |
| SCHEMBL2019221 | 0.85 | EP300 (0.48) | PTPN1LSSEP300PPARG | |
| SCHEMBL2019223 | 0.85 | EP300 (0.48) | PTPN1LSSEP300PPARG | |
| SCHEMBL20027284 | 0.85 | EP300 (0.48) | PTPN1LSSEP300PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025264609-A1 | C20 TRISUBSTITUTED OLEFINS PRODUCED BY ACIDIC CATALYZED REACTION OF C20 2-SUBSTITUTED ALPHA OLEFINS | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2025-12-26 | — | — | WO | claimed |
| US-20250382242-A1 | C20 TRISUBSTITUTED OLEFINS PRODUCED BY ACIDIC CATALYZED REACTION OF C20 2-SUBSTITUTED ALPHA OLEFINS | CHEVRON PHILLIPS CHEMICAL CO LP (US) | 2025-12-18 | — | — | US | claimed |
| WO-2025264609-A1 | C20 TRISUBSTITUTED OLEFINS PRODUCED BY ACIDIC CATALYZED REACTION OF C20 2-SUBSTITUTED ALPHA OLEFINS | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2025-12-26 | — | — | WO | disclosed |
| US-20250382242-A1 | C20 TRISUBSTITUTED OLEFINS PRODUCED BY ACIDIC CATALYZED REACTION OF C20 2-SUBSTITUTED ALPHA OLEFINS | CHEVRON PHILLIPS CHEMICAL CO LP (US) | 2025-12-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250382242-A1 | C20 TRISUBSTITUTED OLEFINS PRODUCED BY ACIDIC CATALYZED REACTION OF C20 2-SUBSTITUTED ALPHA OLEFINS | COASY, MOGAT2, HSD17B12 | PTPN1 4750/4885ACE2 2252/4885LSS 70/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.